AlphaGEN's Other Investors

AlphaGEN raised a round of funding on , . Investors include Mitsubishi UFJ Capital.

The company are developing siRNA drugs targeting a control factor for HIF (hypoxia-inducible factor), which is one of the main factors involved in angiogenesis. The company have found that siRNA can p…

Articles about AlphaGEN's Other Investors: